121 related articles for article (PubMed ID: 15124893)
1. Significant prognostic factors for Vogt-Koyanagi-Harada disease in the early stage.
Sheu SJ; Kou HK; Chen JF
Kaohsiung J Med Sci; 2004 Mar; 20(3):97-105. PubMed ID: 15124893
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for Vogt-Koyanagi-Harada disease.
Sheu SJ; Kou HK; Chen JF
J Chin Med Assoc; 2003 Mar; 66(3):148-54. PubMed ID: 12779034
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of Vogt-Koyanagi-Harada disease in Iran.
Hedayatfar A; Hosseini SM; Karimi N; Falavarjani KG; Badie N; Zameni M; Soheilian M
Int Ophthalmol; 2018 Apr; 38(2):443-449. PubMed ID: 28260142
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
5. Complications and prognostic factors in Vogt-Koyanagi-Harada disease.
Read RW; Rechodouni A; Butani N; Johnston R; LaBree LD; Smith RE; Rao NA
Am J Ophthalmol; 2001 May; 131(5):599-606. PubMed ID: 11336934
[TBL] [Abstract][Full Text] [Related]
6. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
[TBL] [Abstract][Full Text] [Related]
7. Vogt-Koyanagi-Harada disease in children.
Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease.
Quek DT; Jap A; Chee SP
Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937
[TBL] [Abstract][Full Text] [Related]
9. Vitreous surgery for bilateral bullous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Gaun S; Kurimoto Y; Komurasaki Y; Yoshimura N
Ophthalmic Surg Lasers; 2002; 33(6):508-10. PubMed ID: 12449230
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada disease in Thailand.
Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
[TBL] [Abstract][Full Text] [Related]
12. CLINICAL FEATURES AND PROGNOSTIC VALUE OF BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE.
Kwak JJ; Lee J; Byeon SH
Retina; 2023 Oct; 43(10):1700-1707. PubMed ID: 37315551
[TBL] [Abstract][Full Text] [Related]
13. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
Yang P; Sun M
Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
[TBL] [Abstract][Full Text] [Related]
14. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
[TBL] [Abstract][Full Text] [Related]
15. Vogt Koyanagi Harada disease: treatment and visual prognosis.
Alam M; Iqbal M; Khan BS; Hussain I
J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
[TBL] [Abstract][Full Text] [Related]
16. Retinal cystoid spaces in acute Vogt-Koyanagi-Harada syndrome.
Tsujikawa A; Yamashiro K; Yamamoto K; Nonaka A; Fujihara M; Kurimoto Y
Am J Ophthalmol; 2005 Apr; 139(4):670-7. PubMed ID: 15808163
[TBL] [Abstract][Full Text] [Related]
17. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Maruyama Y; Kishi S
Ophthalmic Surg Lasers Imaging; 2004; 35(3):239-42. PubMed ID: 15185793
[TBL] [Abstract][Full Text] [Related]
18. [Vogt-Koyanagi-Harada syndrome. Epidemiological, clinical and disease progression aspects. Twenty cases].
Boutimzine N; Laghmari A; Ouazzani I; Ibrahimy W; Mohcine Z
J Fr Ophtalmol; 1998 Dec; 21(10):746-54. PubMed ID: 10052048
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in Vogt-Koyanagi-Harada disease.
Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D; Abu El-Asrar AM
Int Ophthalmol; 2007; 27(2-3):201-10. PubMed ID: 17435968
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
